Two custom peptides of the same length can differ in price by an order of magnitude — and the reasons are rarely obvious from a quote. Understanding what actually drives the cost of peptide synthesis helps you specify smartly, avoid paying for quality you do not need, and budget realistically as a program scales.
The main cost drivers
- Length: every additional residue adds coupling steps, reagents and impurity risk — cost climbs faster than length.
- Sequence difficulty: aggregation-prone or “difficult” sequences need extra optimization and lower yields.
- Modifications: cyclization, conjugation, labeling, and non-natural amino acids each add specialized chemistry and analytics.
- Purity grade: moving from 95% to 98% or 99% can sharply increase purification effort and material loss.
- Scale: per-milligram cost falls with scale, but absolute cost and route economics change — see scale-up from mg to kg.
- Route: the choice between SPPS and LPPS drives reagent and labor cost, especially at volume.
- Grade: GMP versus research grade adds quality-system, documentation and testing overhead.
Why length and modifications cost so much
Solid-phase synthesis is stepwise: each residue is a coupling and deprotection cycle, each with a small chance of an incomplete reaction that creates a deletion impurity. Those impurities must then be removed in purification, where every percentage point of additional purity can mean significant yield loss. Modifications and difficult sequences compound this — more specialized steps, more analytics, lower yields.
Key point: the biggest avoidable cost is over-specifying. Ordering 99% purity for an application that only needs 95%, or GMP for preclinical work, pays for evidence you will not use.
Purification and analytics
Purification — usually preparative HPLC — is often a larger share of cost than the synthesis itself, particularly for high-purity targets. Analytical release adds further cost but is non-negotiable: robust analytical sciences are what let you trust and defend the material you paid for.
How to control cost without compromising quality
- Specify the purity your application genuinely requires — no more.
- Match the grade to your stage — research grade until you approach the clinic.
- Discuss the route and scale with your manufacturer early, so the process is designed for your eventual volume.
- Consider greener, leaner routes that cut solvent and reagent use at scale.
The best cost control is a conversation up front. A good peptide CDMO will help you right-size purity, grade, route and scale before the first batch — see our complete guide to peptide manufacturing for the full picture.